BSE Live
Apr 06, 16:01Prev. Close
70.00
Open Price
71.99
Bid Price (Qty.)
63.50 (500)
Offer Price (Qty.)
70.00 (123)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Relic Life Science (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.23 | -0.30 | 0.16 | 0.28 | 0.39 | |
| Diluted EPS (Rs.) | 0.23 | -0.30 | 0.16 | 0.28 | 0.39 | |
| Cash EPS (Rs.) | 0.49 | -0.06 | 0.34 | 0.44 | 0.60 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 11.09 | 10.87 | 11.16 | 11.26 | 10.97 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 11.09 | 10.87 | 11.16 | 11.26 | 10.97 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 2.13 | 2.33 | 4.41 | 3.42 | 3.05 | |
| PBDIT/Share (Rs.) | 0.53 | 0.17 | 0.50 | 0.60 | 1.97 | |
| PBIT/Share (Rs.) | 0.26 | -0.07 | 0.32 | 0.44 | 1.77 | |
| PBT/Share (Rs.) | 0.23 | -0.11 | 0.30 | 0.41 | 1.73 | |
| Net Profit/Share (Rs.) | 0.23 | -0.30 | 0.16 | 0.28 | 0.39 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 24.80 | 7.46 | 11.42 | 17.63 | 64.77 | |
| PBIT Margin (%) | 12.30 | -2.93 | 7.33 | 12.98 | 57.99 | |
| PBT Margin (%) | 10.85 | -4.66 | 6.70 | 12.10 | 56.72 | |
| Net Profit Margin (%) | 10.66 | -12.87 | 3.65 | 8.26 | 12.79 | |
| Return on Networth / Equity (%) | 2.05 | -2.75 | 1.44 | 2.51 | 3.55 | |
| Return on Capital Employed (%) | 1.54 | -2.02 | 1.04 | 1.80 | 2.46 | |
| Return on Assets (%) | 1.48 | -1.96 | 1.00 | 1.79 | 2.45 | |
| Total Debt/Equity (X) | 0.33 | 0.36 | 0.38 | 0.38 | 0.42 | |
| Asset Turnover Ratio (%) | 13.96 | 15.22 | 27.53 | 21.67 | 19.21 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 16.86 | 18.05 | 16.16 | 93.30 | 137.65 | |
| Quick Ratio (X) | 16.86 | 18.05 | 16.16 | 93.30 | 137.65 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 100.00 | 0.00 | 100.00 | 100.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 0.00 | 100.00 | 100.00 | 100.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 5.58 | 4.21 | 3.68 | 4.26 | 4.52 | |
| EV/Net Operating Revenue (X) | 7.26 | 5.03 | 2.32 | 3.46 | 4.12 | |
| EV/EBITDA (X) | 29.28 | 67.34 | 20.29 | 19.63 | 6.36 | |
| MarketCap/Net Operating Revenue (X) | 5.96 | 3.63 | 1.68 | 2.51 | 2.84 | |
| Retention Ratios (%) | 100.00 | 0.00 | 100.00 | 100.00 | 100.00 | |
| Price/BV (X) | 1.15 | 0.78 | 0.66 | 0.76 | 0.79 | |
| Price/Net Operating Revenue | 5.97 | 3.64 | 1.68 | 2.51 | 2.84 | |
| Earnings Yield | 0.02 | -0.04 | 0.02 | 0.03 | 0.04 |
14.11.2025
Relic Life Scie Consolidated September 2025 Net Sales at Rs 0.60 crore, down 5.44% Y-o-Y
29.07.2025
Relic Life Scie Consolidated June 2025 Net Sales at Rs 1.28 crore, up 214.94% Y-o-Y
03.06.2025
Relic Life Scie Consolidated March 2025 Net Sales at Rs 0.47 crore, up 22.43% Y-o-Y
28.05.2025
Relic Life Scie Standalone March 2025 Net Sales at Rs 0.16 crore, down 59.42% Y-o-Y
14.11.2025
Relic Life Scie Consolidated September 2025 Net Sales at Rs 0.60 crore, down 5.44% Y-o-Y
29.07.2025
Relic Life Scie Consolidated June 2025 Net Sales at Rs 1.28 crore, up 214.94% Y-o-Y
03.06.2025
Relic Life Scie Consolidated March 2025 Net Sales at Rs 0.47 crore, up 22.43% Y-o-Y
28.05.2025
Relic Life Scie Standalone March 2025 Net Sales at Rs 0.16 crore, down 59.42% Y-o-Y
28.05.2024
28.05.2024
Bulk deals: Kotak Mahindra MF buys 3.86% in Prudent Corporate Advisory Services
27.05.2024
29.04.2024
Buy UTI Asset Management Company; target of Rs 1050: Prabhudas Lilladher